Why healthcare M&A slipped into Q4: an expert briefing with Rebecca Springer and Collin Anderson, Bailey & Company

Rebecca Springer, Senior Director, Market Development, and Collin Anderson, Associate, Market Development, at Bailey & Company, sat down with HTN's Martin Cech on November 5, 2026 to discuss why Q3 deal closings slipped into Q4, why B and C assets are coming to market, deal activity in staffing, behavioral health and RCM, and ICHRA's growth outlook.